Quest, Beth Israel, Weill Cornell Collaborate on MDx for Organ Renal Transplant Rejection | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quest Diagnostics has teamed up with Beth Israel Deaconess Medical Center and Weill Cornell Medical College to launch a molecular blood test for identifying renal organ transplant rejection.

Quest has also formed R&D collaboration deals with Beth Israel Deaconess and Weill Cornell in the area of renal transplantation, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.